Type 2 diabetes

#Research study #Type 2 diabetes

Blood pressure drugs could protect against Type 2 diabetes 

Lowering high blood pressure is an effective way to reduce a person’s risk of developing Type 2 diabetes in the future, according to research funded by the British Heart Foundation (BHF) and published in The Lancet.  Doctors already prescribe blood pressure-lowering drugs to reduce a person’s chance… Read More

#News

#Clinical trials #Diabetes #Research #Type 2 diabetes

Preclinical data on oral polymer-based duodenal exclusion therapy

Glyscend has presented data during the American Diabetes Association 80th Scientific Sessions virtual meeting, from a study of its proprietary oral polymer duodenal exclusion therapy. The positive data were presented ahead of Glyscend’s Phase I clinical trials, which have commenced recruiting healthy subjects in South Australia. Glyscend is developing a… Read More

#News

#Clinical trial #Diabetes #Drug development #GlobalData #Type 2 diabetes

Eli Lilly’s tirzepatide continues to outperform popular diabetes drugs

Eli Lilly’s tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 receptor agonist (GLP-1RA), recently demonstrated that it was able to not only reduce HbA1c levels in type 2 diabetes (T2D) patients, but also confer weight loss when compared to insulin glargine in the SURPASS-4 trial. Tirzepatide… Read More

#News #Trends & Analysis

#Diabetes #Drug development #Drug discovery #Type 2 diabetes

Muscle gene linked to Type 2 diabetes

Research published in Nature Communications by a team from Lund University in Sweden has discovered that in Type 2 diabetes, a specific gene influences muscle stem cells’ ability to create new mature muscle cells. “In people with Type 2 diabetes, the VPS39 gene is significantly less active in the muscle… Read More

#News

#Diabetes #Drug development #Drug discovery #Research study #Type 2 diabetes

Two new diabetes drugs may work better for Asian people

According to new research, two new but commonly-used diabetes drugs, one of which is also now approved for use in heart failure in people with or without diabetes, might be more effective in people with an Asian background than in people with a White… Read More

#News